Metoprolol Retard Ratiopharm

Metoprolol Tartrate, the active ingredient in Metoprolol Retard Ratiopharm, is a beta‑adrenergic blocking agent presented as an extended‑release tablet for oral use. It treats hypertension, angina pectoris, post‑myocardial infarction care, chronic heart failure and certain cardiac arrhythmias in adult patients.

GNH USA supplies Metoprolol Retard Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprolol Retard is a selective β1‑adrenergic blocker used in cardiovascular disease management. - Hypertension: lowers blood pressure by reducing heart rate and cardiac output. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. - Post‑myocardial infarction: improves survival by reducing cardiac workload and arrhythmia risk. - Chronic heart failure: enhances ventricular function and reduces hospitalizations. - Certain cardiac arrhythmias: controls heart rate in atrial fibrillation and other supraventricular tachyarrhythmias.

Metoprolol Retard may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Fatigue: feeling of tiredness or lack of energy. - Dizziness: light‑headedness, especially on standing. - Bradycardia: slower than normal heart rate.

Serious or Rare Side Effects: - Severe bradycardia: heart rate dropping to dangerously low levels. - Heart block: impairment of electrical conduction between atria and ventricles. - Bronchospasm: narrowing of airways, particularly in patients with asthma.

When prescribing Metoprolol Retard, clinicians should consider several precautionary measures to ensure safe use. - Assess cardiac function: evaluate heart rate and blood pressure before initiation. - Review respiratory history: avoid in patients with severe asthma or chronic obstructive pulmonary disease. - Monitor for diabetes: beta‑blockers may mask hypoglycaemia symptoms. - Caution in renal impairment: dose adjustment may be required in reduced kidney function. - Avoid abrupt discontinuation: taper gradually to prevent rebound tachycardia or hypertension. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture.

Metoprolol Retard can interact with other medicines, altering its effectiveness or increasing risk of adverse events.

Major Interactions (Avoid): - Non‑selective beta‑blockers: concurrent use may cause excessive bradycardia. - Calcium channel blockers (verapamil, diltiazem): can lead to profound heart block or hypotension. - Antidiabetic agents: may mask hypoglycaemia signs, requiring dose adjustments.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: additive blood pressure lowering effect. - NSAIDs (ibuprofen, naproxen): may reduce antihypertensive efficacy. - Antidepressants (SSRIs, tricyclics): can increase plasma levels of metoprolol.